Literature DB >> 34559955

LINC00662 facilitates osteosarcoma progression via sponging miR-103a-3p and regulating SIK2 expression.

Jianghu Huang1,2, Feiyue Lin1,2, Chuncai Xu1,2, Yang Xu1,2.   

Abstract

Long non-coding RNA (lncRNA) involvement in regulating assorted cancers has been determined. Long intergenic non-protein coding RNA 662 (LINC00662) has been studied in gastric cancer. However, its function was not elucidated in osteosarcoma (OS). Thus, we aimed to discover LINC00662 function and the corresponding mechanism in OS. In this study, we found that LINC00662 displayed high expression in OS cells. LINC00662 down-regulation negatively affected OS cell malignant behaviors and tumor growth. Subsequently, miR-103a-3p was proven to bind with LINC00662 and overexpression of miR-103a-3p inhibited OS cell proliferation, migration and invasion. Then, SIK2, the downstream of miR-103a-3p, was up-regulated in OS cells and positively regulated by LINC00662. In addition, knockdown of SIK2 exerted inhibitory effects on proliferative, migratory and invaded capacities of OS cells. More interestingly, miR-103a-3p depletion or SIK2 overexpression restored the impacts of down-regulated LINC00662 on OS cells. In conclusion, LINC00662 could facilitate OS progression via miR-103a-3p/SIK2 axis.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  LINC00662; SIK2; miR-103a-3p; osteosarcoma

Mesh:

Substances:

Year:  2021        PMID: 34559955     DOI: 10.1002/term.3242

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  1 in total

1.  Effects of miR-103a-3p Targeted Regulation of TRIM66 Axis on Docetaxel Resistance and Glycolysis in Prostate Cancer Cells.

Authors:  Qiang Yi; Junfeng Wei; Yangzhou Li
Journal:  Front Genet       Date:  2022-02-08       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.